Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03693612 |
| Title | GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Boston | Massachusetts | 02215 | United States | Details | |
| GSK Investigational Site | New York | New York | 10016-4744 | United States | Details | |
| GSK Investigational Site | New York | New York | 10032 | United States | Details | |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
| GSK Investigational Site | San Antonio | Texas | 78229 | United States | Details | |
| GSK Investigational Site | Melbourne | Victoria | 3000 | Australia | Details | |
| GSK Investigational Site | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
| GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details |